Literature DB >> 30443742

Spinal cord lesions in a pediatric patient with chronic kidney disease and review of literature: Answers.

Harmanpreet Tiwana1, Himadri Patel2, Sheila Asghar2, Ashutosh Kumar2, Michael Freeman2.   

Abstract

Entities:  

Year:  2018        PMID: 30443742     DOI: 10.1007/s00467-018-4138-5

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


× No keyword cloud information.
  6 in total

1.  Spinal cord involvement during hypertensive encephalopathy: clinical and radiological findings.

Authors:  Antonio Milia; J Moller; G Pilia; M G Mascia; P Marchi; M Mura; M G Marrosu
Journal:  J Neurol       Date:  2008-01-18       Impact factor: 4.849

2.  Neurological picture. Spinal cord involvement in posterior reversible encephalopathy syndrome.

Authors:  B Lapuyade; I Sibon; S Jeanin; V Dousset
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-01       Impact factor: 10.154

3.  Asymptomatic spinal cord involvement in posterior reversible encephalopathy syndrome.

Authors:  C Briganti; M Caulo; F Notturno; A Tartaro; A Uncini
Journal:  Neurology       Date:  2009-11-03       Impact factor: 9.910

4.  PRES with asymptomatic spinal cord involvement. Is this scenario more common than we know?

Authors:  L C P Marrone; W A Martins; J P F Brunelli; H Fussiger; G F Carvalhal; J R H Filho; R B Soder; M Schuck; F S Viola; A C H Marrone; J C da Costa
Journal:  Spinal Cord Ser Cases       Date:  2016-01-07

5.  Posterior reversible encephalopathy syndrome with spinal cord involvement.

Authors:  Adam de Havenon; Zachary Joos; Loren Longenecker; Lubdha Shah; Safdar Ansari; Kathleen Digre
Journal:  Neurology       Date:  2014-10-29       Impact factor: 9.910

6.  Involvement of the cervical cord and medulla in posterior reversible encephalopathy syndrome.

Authors:  Naseer A Choh; Majid Jehangir; Muddassir Rasheed; Tajamul Mira; Irfan Ahmad; Suhil Choh
Journal:  Ann Saudi Med       Date:  2011 Jan-Feb       Impact factor: 1.526

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.